A controversial startup that was charging $8,000 to fill your veins with young blood says it’s halted operations after a warning from regulators 0 19.02.2019 20:19 BusinessInsider.sg Federal regulators warned people against getting infusions of young blood on Tuesday. Following the warning, a startup called Ambrosia allegedly ceased operations. They'd been charging $8,000 for the procedure despite little hard science. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
